GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition
- PMID: 18382465
- PMCID: PMC2709246
- DOI: 10.1038/nrn2370
GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition
Abstract
GABA (gamma-aminobutyric acid) type A receptors (GABA(A)Rs) mediate most fast synaptic inhibition in the mammalian brain, controlling activity at both the network and the cellular levels. The diverse functions of GABA in the CNS are matched not just by the heterogeneity of GABA(A)Rs, but also by the complex trafficking mechanisms and protein-protein interactions that generate and maintain an appropriate receptor cell-surface localization. In this Review, we discuss recent progress in our understanding of the dynamic regulation of GABA(A)R composition, trafficking to and from the neuronal surface, and lateral movement of receptors between synaptic and extrasynaptic locations. Finally, we highlight a number of neurological disorders, including epilepsy and schizophrenia, in which alterations in GABA(A)R trafficking occur.
Figures





Similar articles
-
The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapses.Physiol Rev. 2011 Jul;91(3):1009-22. doi: 10.1152/physrev.00015.2010. Physiol Rev. 2011. PMID: 21742794 Free PMC article. Review.
-
GABAA receptor trafficking-mediated plasticity of inhibitory synapses.Neuron. 2011 May 12;70(3):385-409. doi: 10.1016/j.neuron.2011.03.024. Neuron. 2011. PMID: 21555068 Free PMC article. Review.
-
Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses.Pharmacol Ther. 2004 Jun;102(3):195-221. doi: 10.1016/j.pharmthera.2004.04.003. Pharmacol Ther. 2004. PMID: 15246246 Review.
-
Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.Nat Rev Neurosci. 2005 Mar;6(3):215-29. doi: 10.1038/nrn1625. Nat Rev Neurosci. 2005. PMID: 15738957 Review.
-
Interaction of different proteins with GABAA receptor and their modulatory effect on inhibitory neural transmission leads to epilepsy.CNS Neurol Disord Drug Targets. 2014;13(7):1148-59. doi: 10.2174/1871527313666140917115121. CNS Neurol Disord Drug Targets. 2014. PMID: 25230226 Review.
Cited by
-
Clinical Potential of Neurosteroids for CNS Disorders.Trends Pharmacol Sci. 2016 Jul;37(7):543-561. doi: 10.1016/j.tips.2016.04.003. Epub 2016 May 5. Trends Pharmacol Sci. 2016. PMID: 27156439 Free PMC article. Review.
-
Aging Affects Neural Synchronization to Speech-Related Acoustic Modulations.Front Aging Neurosci. 2016 Jun 15;8:133. doi: 10.3389/fnagi.2016.00133. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27378906 Free PMC article.
-
Structure of a human synaptic GABAA receptor.Nature. 2018 Jul;559(7712):67-72. doi: 10.1038/s41586-018-0255-3. Epub 2018 Jun 27. Nature. 2018. PMID: 29950725 Free PMC article.
-
Experimental Traumatic Brain Injury Induces Chronic Glutamatergic Dysfunction in Amygdala Circuitry Known to Regulate Anxiety-Like Behavior.Front Neurosci. 2020 Jan 21;13:1434. doi: 10.3389/fnins.2019.01434. eCollection 2019. Front Neurosci. 2020. PMID: 32038140 Free PMC article.
-
Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.Elife. 2017 Nov 14;6:e28685. doi: 10.7554/eLife.28685. Elife. 2017. PMID: 29135436 Free PMC article.
References
-
- Sieghart W, Sperk G. Subunit composition, distribution and function of GABAA receptor subtypes. Curr Top Med Chem. 2002;2:795–816. - PubMed
-
- Rudolph U, Mohler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol. 2004;44:475–498. - PubMed
-
- Bormann J, Feigenspan A. GABAC receptors. Trends Neurosci. 1995;18:515–519. - PubMed
-
- Couve A, Moss SJ, Pangalos MN. GABAB receptors: a new paradigm in G protein signaling. Mol Cell Neurosci. 2000;16:296–312. - PubMed
-
- Bettler B, Tiao JY. Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther. 2006;110:533–543. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS056359/NS/NINDS NIH HHS/United States
- R01 NS048045/NS/NINDS NIH HHS/United States
- R01 NS081986/NS/NINDS NIH HHS/United States
- NS048045/NS/NINDS NIH HHS/United States
- NS051195/NS/NINDS NIH HHS/United States
- R01 NS051195/NS/NINDS NIH HHS/United States
- MRC_/Medical Research Council/United Kingdom
- P01 NS054900/NS/NINDS NIH HHS/United States
- NS046478/NS/NINDS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 NS056359/NS/NINDS NIH HHS/United States
- P01NS054900/NS/NINDS NIH HHS/United States
- R01 NS047478/NS/NINDS NIH HHS/United States
- R01 NS046478/NS/NINDS NIH HHS/United States
- R21 NS080064/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases